Shibo Jiang

1.9k total citations · 1 hit paper
60 papers, 1.4k citations indexed

About

Shibo Jiang is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Shibo Jiang has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 19 papers in Molecular Biology and 18 papers in Virology. Recurrent topics in Shibo Jiang's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (10 papers) and Immune Cell Function and Interaction (9 papers). Shibo Jiang is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (10 papers) and Immune Cell Function and Interaction (9 papers). Shibo Jiang collaborates with scholars based in China, United States and Hong Kong. Shibo Jiang's co-authors include Lu Lu, Lanying Du, Wei Xu, Asim K. Debnath, Shuai Xia, Qian Wang, Bei Yang, Lei Yan, Ian A. Wilson and Wenjie Tan and has published in prestigious journals such as Cell, Nucleic Acids Research and Advanced Materials.

In The Last Decade

Shibo Jiang

56 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

2019 374 citations Lanying Du, Wenjie Tan et al. profile →

Peers

Countries citing papers authored by Shibo Jiang

Since Specialization

Citations

This map shows the geographic impact of Shibo Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibo Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibo Jiang more than expected).

Fields of papers citing papers by Shibo Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shibo Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibo Jiang. The network helps show where Shibo Jiang may publish in the future.

Co-authorship network of co-authors of Shibo Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Shibo Jiang. A scholar is included among the top collaborators of Shibo Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shibo Jiang. Shibo Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regenerating Family Protein 3α‐Loaded Responsive Hydrogel Accelerates Infected Diabetic Wound Healing 2025 ·Advanced Healthcare Materials ·Qingyun Wu, Shibo Jiang, Jia Liu, Lili Ren, Chen Luo, Guoguang Chen, Luting Yu	3
2	Screening and discovery of an antiviral candidate inhibiting the SARS-CoV-2 envelope (2-E) channel 2025 ·Current Research in Microbial Sciences ·Han Zhang, (unknown), (unknown), (unknown), Yan Zhang, Ziyue Li, (unknown), (unknown), Jingshan Shen, Xi Cheng, Shibo Jiang, Zhaobing Gao, Xinling Wang, Xiangrui Jiang, Bingqing Xia	1
3	Thermodynamically Self‐Limiting Presodiation Inducing Homogeneous Inorganic–Organic Polymer‐Skeleton Interphases for Durable Sodium‐Ion Batteries 2025 ·Advanced Materials ·Shibo Jiang, (unknown), (unknown), (unknown), (unknown), Kefa Cen, Jianhua Yan, Zheng Bo, Jun Lü, Huachao Yang	0
4	A clinically used anti‐human papilloma virus agent (3‐hydroxyphthalic anhydride‐modified bovine β‐lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus 2024 ·SHILAP Revista de lepidopterología ·(unknown), Baoying Huang, Hua Chen, Yun Zhu, Wanbo Tai, (unknown), Yixin Li, Anqi Xia, Qiao Wang, Lu Lu, Wenjie Tan, Shibo Jiang	1
5	A gossypol derivative effectively protects against Zika and dengue virus infection without toxicity 2022 ·BMC Biology ·(unknown), Wanbo Tai, Xinyi Wang, Shibo Jiang, Asim K. Debnath, Lanying Du, Shizhong Chen	10
6	Real-time imaging of individual virion-triggered cortical actin dynamics for human immunodeficiency virus entry into resting CD4 T cells 2019 ·Nanoscale ·Wen Yin, Wei Li, Qin Li, Yuanyuan Liu, Liu Ji, (unknown), Yingxin Ma, Zhiping Zhang, Xiaowei Zhang, Yuntao Wu, Shibo Jiang, Xian‐En Zhang, Zongqiang Cui	25
7	De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery 2018 ·Journal of Medicinal Chemistry ·Chao Wang, (unknown), (unknown), Tianhong Zhang, Ruiyuan Cao, Guodong Liang, Yue Li, (unknown), Weicong Wang, Weiguo Shi, Wu Zhong, Shibo Jiang, Keliang Liu	46
8	Combining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice 2017 ·Scientific Reports ·Chenglai Xia, Ruihong Chen, Jinman Chen, Qianqian Qi, Yanbin Pan, Lanying Du, Guohong Xiao, Shibo Jiang	34
9	De novo design of isopeptide bond-tethered triple-stranded coiled coils with exceptional resistance to unfolding and proteolysis: implication for developing antiviral therapeutics 2015 ·Chemical Science ·Chao Wang, Wenqing Lai, Fei Yu, Tianhong Zhang, Lu Lu, (unknown), Zhenqing Zhang, Xiaoyu Xu, Yu Bai, Shibo Jiang, Keliang Liu	14
10	An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications 2015 ·Chemical Science ·Wenqing Lai, Chao Wang, Fei Yu, Lu Lu, Qian Wang, (unknown), Xiaoyu Xu, Tianhong Zhang, Shengming Wu, Xi Zheng, Zhenqing Zhang, Fangting Dong, Shibo Jiang, Keliang Liu	14
11	HIV-1 impairs human retinal pigment epithelial barrier function: possible association with the pathogenesis of HIV-associated retinopathy 2014 ·Laboratory Investigation ·Suiyi Tan, (unknown), Tianrong Xun, (unknown), Jiayin Qiu, Fei Yu, (unknown), Linxuan Wu, Lin Li, Lu Lu, Shibo Jiang, Shuwen Liu	22
12	Complement Inhibition Alleviates Paraquat-Induced Acute Lung Injury 2011 ·American Journal of Respiratory Cell and Molecular Biology ·Shihui Sun, Hanbin Wang, Guangyu Zhao, (unknown), Yan Guo, Lanying Du, Hongbin Song, Fei Qiao, Hong Yu, Xiaohong Wu, Carl Atkinson, Shibo Jiang, Stephen Tomlinson, Yusen Zhou	37
13	Prolongation of corneal xenotransplant survival by T‐cell vaccination‐induced T‐regulatory cells 2008 ·Xenotransplantation ·Jing Wang, Shibo Jiang, (unknown), Ying Lin, Jufang Wang, Xiaoning Wang	10
14	Improbability of Harmful Autoimmune Responses Resulting from Immunization with HIV-1 Envelope Glycoproteins 1993 ·AIDS Research and Human Retroviruses ·A. R. Neurath, N. Strick, (unknown), Shibo Jiang	5
15	Antibody Responses of Chimpanzees Immunized with Synthetic Peptides Corresponding to Full-Length V3 Hypervariable Loops of HIV-1 Envelope Glycoproteins 1991 ·AIDS Research and Human Retroviruses ·A. R. Neurath, Shibo Jiang, (unknown), Hanno V.J. Kolbe, Marie-Paule Kiény, Elizabeth Muchmore, Marc Girard	25
16	Peptides Mimicking Selected Disulfide Loops in HIV-1 gp120, Other Than V3, Do Not Elicit Virus-Neutralizing Antibodies 1991 ·AIDS Research and Human Retroviruses ·A. R. Neurath, N. Strick, Robert Fields, Shibo Jiang	8
17	Resistance to the pore-forming protein of cytotoxic T cells: Comparison of target cell membrane rigidity 1990 ·Molecular Immunology ·David M. Ojcius, Shibo Jiang, Pedro M. Persechini, Judith Storch, John D. Young	6
18	Restriction factors of homologous complement: A new candidate? 1990 ·Immunology Today ·David M. Ojcius, Shibo Jiang, John Ding‐E Young	40
19	Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity. 1989 ·The Journal of Experimental Medicine ·C C Liu, Shibo Jiang, Pedro M. Persechini, Arturo Zychlinsky, Yael Kaufmann, John Ding‐E Young	28
20	The lymphocyte pore-forming protein perforin is associated with granules by a pH-dependent mechanism 1989 ·Immunology Letters ·Pedro M. Persechini, Chau‐Ching Liu, Shibo Jiang, John Ding‐E Young	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact